Business · 13/03/2019Updated: 10/17/2026 · 1 min read

FDA Announces Draft Guidance on Cancer Clinical Trial Eligibility for Patients with HIV, Hepatitis B, or Hepatitis C

The FDA is releasing a draft guidance outlining eligibility criteria for cancer clinical trials for patients with HIV, Hepatitis B, or Hepatitis C, aiming to increase inclusivity and accelerate cancer treatment development